29Oct
Related Posts
14May
CytoAgents Receives NIH Funding to Accelerate Treatment for Cytokine Storm
CytoAgents awarded $1.6 million National Institutes of Health (NIH) grant to accelerate treatment for cytokine storm. read more
05Nov
India to Start Clinical Trials of US-Based Second Generation, Low-Cost Covid-19 Vaccine
India will soon start clinical trials of US-based Akston Biosciences second-generation Covid-19 vaccine — one of the most promising candidates... read more
07Aug
Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today reported financial... read more
15Nov
Polaroid. The long, slow demise of a tech giant.
Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about... read more
06Mar
Wasabi Launches White Label OEM Program for Partners to Brand Their Own Cloud Storage
Wasabi Technologies, the hot cloud storage company, has made its award-winning cloud storage available to SaaS, Cloud Services Providers, and... read more
05Aug
Looking for Love? These Are the Best Dating Apps You Can Try
The dating app S'More has basically the same concept as the Netflix show Love Is Blind, and wow, is it... read more
22Jan
Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced it... read more
08Jun
Smart glasses give legally blind man second chance to see his wife at their wedding
A pair of eSight 3 smart glasses have given Airey something close to 20/20 vision. Recently Airey and his family... read more
16Jun
An MIT Party!
Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast,... read more
13Jun
Myomo closes $5m IPO
Myomo said last week it closed its initial public offering, raising $5 million and listing on the New York Stock... read more